Zinc for Type 2 Diabetes

Verdict: Published with Warning

Across 5 PubMed studies, the evidence for Zinc in Type 2 Diabetes grades Tier C — weak evidence. Effective, but with safety or population caveats.

C 🟠 C Weak Evidence Published with Warning

🔬Why this grade7-layer evidence engine

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.64
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published with Warning
Confidence
83%
Highly consistent evidence
Evidence level
E1
Cochrane high-quality SR/MA

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.47
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.65
L2 PubMedPrimary literature
0.75
L3 MechanismPlausibility
0.75
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.644
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (3 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance
PMID: 26020622 2015 Cochrane Review n = 128
Finding: Across 3 small RCTs (128 participants) NO study reported the prespecified clinical endpoints (incidence of T2DM, mortality, complications); zinc had a neutral effect on the surrogate HOMA-IR, and authors concluded there is currently no evidence on which to base the use of zinc for preventing type 2 diabetes.
🟢 High quality Government Effect size: HOMA-IR: neutral (no significant difference vs control); hard clinical endpoints not reported
View on PubMed
Zinc supplementation improves glycemic control for diabetes prevention and management: a systematic review and meta-analysis of randomized controlled trials
PMID: 31161192 2019 統合分析 n = 1,700
Finding: Pooling 32 placebo-controlled RCTs (~1700 participants), zinc significantly reduced fasting glucose (WMD -14.15 mg/dL, 95% CI -17.36 to -10.93) and HbA1c (WMD -0.55%, 95% CI -0.84 to -0.27), with concurrent falls in 2-h glucose, fasting insulin and HOMA-IR.
Academic Effect size: HbA1c WMD -0.55% (95% CI -0.84 to -0.27); fasting glucose WMD -14.15 mg/dL (95% CI -17.36 to -10.93)
View on PubMed
Triangulating evidence for the causal impact of single-intervention zinc supplement on glycaemic control for type 2 diabetes: systematic review and meta-analysis of randomised controlled trial and two-sample Mendelian randomisation
PMID: 35946077 2023 統合分析 n = 897
Finding: Meta-analysis of 14 RCTs (897 participants) found zinc reduced fasting glucose (MD -26.52 mg/dl, 95% CI -35.13 to -17.91), HbA1c (MD -0.52%, 95% CI -0.90 to -0.13) and HOMA-IR (MD -1.65, 95% CI -2.62 to -0.68), and a concordant Mendelian-randomisation signal (IVW -2.04 mmol/l, 95% CI -3.26 to -0.83) supported a causal direction.
Effect size: HbA1c MD -0.52% (95% CI -0.90 to -0.13); MR fasting glucose IVW -2.04 mmol/l (95% CI -3.26 to -0.83)
View on PubMed
Zinc's role in the glycemic control of patients with type 2 diabetes: a systematic review
PMID: 28138861 2017 系統性回顧
Finding: A narrative synthesis of 15 studies (only 3 interventional, 12 observational; total N not reported) reported that HbA1c significantly decreased with zinc supplementation and was inversely correlated with plasma zinc, but the predominantly observational design and absence of a pooled estimate limit the inference.
🟠 Limited quality Effect size: No pooled effect estimate reported (HbA1c qualitatively reduced; negative HbA1c-plasma zinc correlation)
View on PubMed
Effect of Zinc Supplementation on Glycemic Control in Newly Diagnosed Patients With Type 2 Diabetes Mellitus
PMID: 39398666 2024 RCT (double-blind) n = 80
Finding: In 80 newly-diagnosed T2DM patients on metformin, adding 50 mg/day zinc for 12 months produced significantly greater reductions than placebo in HbA1c (-0.79%), fasting glucose (-21.52 mg/dL) and postprandial glucose (-47.53 mg/dL), though specific p-values were not reported in the abstract.
🟠 Limited quality Academic Effect size: HbA1c -0.79%; fasting glucose -21.52 mg/dL; postprandial glucose -47.53 mg/dL (between-group, p-values not stated)
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4b EU EFSA
Supportive
contributes to normal function of the immune system source↗
L4c UK NHS
Cautious
You should be able to get all the zinc you need from your daily diet source↗
L4d TW TFDA / 衛福部
Supportive
鋅之每日最高攝食量不得超過30 mg source↗
L4e WHO
Supportive
zinc has been recommended by WHO and UNICEF as the only treatment to be coupled with oral rehydration salts for the treatment of all diarrhoea episodes source↗
L5a NIH Office of Dietary Supplements
Supportive
Zinc is an essential mineral involved in numerous aspects of cellular metabolism source↗
L5b Mayo Clinic
Neutral
Zinc supplements are used to prevent or treat zinc deficiency. People who have low levels of zinc seem to benefit most from zinc supplements. Research suggests zinc supplements taken by mouth might slow the progression of age-related macular degeneration. Taken soon after cold symptoms start, zinc might shorten the length of a cold. People who have wounds such as skin ulcers and who also have l… source↗
L5c Cleveland Clinic
Cautious
For reasons that aren't clear, people with Type 2 diabetes are often low in zinc. Some experts believe these low zinc levels may make the disease progress quickly. Different studies suggest that zinc may lower blood sugar and high cholesterol in people with Type 2 diabetes. source↗
L5e Specialty Society (condition-mapped)
Cautious
The ADA's Standards of Care does not recommend taking supplements unless you have been diagnosed with a nutrient deficiency. Supplements are not proven as an effective option for lowering your blood glucose or supporting diabetes management. Without underlying deficiency, there is no benefit from herbal or nonherbal (i.e., vitamin or mineral) supplementation for people with diabetes. source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬5 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-type2-diabetes-INT-zinc-001 繁體中文版 →